Photo by nci from unsplash
Supply of cytomegalovirus (CMV)‐seronegative blood products in Australia is an ongoing challenge. Requests for CMV‐negative products are increasing with prediction that the demand will exceed supply by 2019. Clinical information… Click to show full abstract
Supply of cytomegalovirus (CMV)‐seronegative blood products in Australia is an ongoing challenge. Requests for CMV‐negative products are increasing with prediction that the demand will exceed supply by 2019. Clinical information evaluating how these products are being utilized by health providers within Australia is limited. This study aimed to identify indications for use of CMV‐negative blood products and gather data to support possible practice change.
Keywords:
analysis fate;
blood;
products derived;
blood products;
fate selection;
selection blood
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Transfusion
Year Published: 2018
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!